BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23209849)

  • 1. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
    Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
    PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes.
    De Rycker M; O'Neill S; Joshi D; Campbell L; Gray DW; Fairlamb AH
    PLoS Negl Trop Dis; 2012; 6(11):e1932. PubMed ID: 23209868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.
    Sykes ML; Avery VM
    Am J Trop Med Hyg; 2009 Oct; 81(4):665-74. PubMed ID: 19815884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-organism high-throughput screening against Trypanosoma brucei brucei.
    Jones AJ; Avery VM
    Expert Opin Drug Discov; 2013 May; 8(5):495-507. PubMed ID: 23540598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.
    Sykes ML; Avery VM
    Parasit Vectors; 2009 Nov; 2(1):54. PubMed ID: 19909542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sickness.
    Navarro G; Chokpaiboon S; De Muylder G; Bray WM; Nisam SC; McKerrow JH; Pudhom K; Linington RG
    PLoS One; 2012; 7(9):e46172. PubMed ID: 23029428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of resazurin-based assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei rhodesiense strain STIB 900 for the identification of potential anti-trypanosomal agents.
    Lim KT; Zahari Z; Amanah A; Zainuddin Z; Adenan MI
    Exp Parasitol; 2016 Mar; 162():49-56. PubMed ID: 26772786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
    Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
    J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
    Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
    Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.
    Rahmani R; Ban K; Jones AJ; Ferrins L; Ganame D; Sykes ML; Avery VM; White KL; Ryan E; Kaiser M; Charman SA; Baell JB
    J Med Chem; 2015 Sep; 58(17):6753-65. PubMed ID: 26247439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrypanosomal activity of some medicinal plants from Nigerian ethnomedicine.
    Abiodun OO; Gbotosho GO; Ajaiyeoba EO; Brun R; Oduola AM
    Parasitol Res; 2012 Feb; 110(2):521-6. PubMed ID: 21789586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign.
    Diaz R; Luengo-Arratta SA; Seixas JD; Amata E; Devine W; Cordon-Obras C; Rojas-Barros DI; Jimenez E; Ortega F; Crouch S; Colmenarejo G; Fiandor JM; Martin JJ; Berlanga M; Gonzalez S; Manzano P; Navarro M; Pollastri MP
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3253. PubMed ID: 25340575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent Antitrypanosomal Activities of 3-Aminosteroids against African Trypanosomes: Investigation of Cellular Effects and of Cross-Resistance with Existing Drugs.
    Nnadi CO; Ebiloma GU; Black JA; Nwodo NJ; Lemgruber L; Schmidt TJ; de Koning HP
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aroyl guanidine anti-trypanosomal compounds that exert opposing effects on parasite energy metabolism.
    Varghese S; Srivastava A; Wong SW; Le T; Pitcher N; Mesnard M; Lallemand C; Rahmani R; Moawad SR; Huang F; He T; Sleebs BE; Barrett MP; Sykes ML; Avery VM; Creek DJ; Baell JB
    Eur J Med Chem; 2024 Mar; 268():116162. PubMed ID: 38394930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
    Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.